﻿<?xml version="1.0" encoding="utf-8"?>
<Return xmlns="http://www.irs.gov/efile" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.irs.gov/efile" returnVersion="2018v3.1">
  <ReturnHeader binaryAttachmentCnt="0">
    <ReturnTs>2019-11-15T13:29:39-06:00</ReturnTs>
    <TaxPeriodEndDt>2018-12-31</TaxPeriodEndDt>
    <PreparerFirmGrp>
      <PreparerFirmEIN>560574444</PreparerFirmEIN>
      <PreparerFirmName>
        <BusinessNameLine1Txt>CHERRY BEKAERT LLP</BusinessNameLine1Txt>
      </PreparerFirmName>
      <PreparerUSAddress>
        <AddressLine1Txt>11200 ROCKVILLE PIKE SUITE 400</AddressLine1Txt>
        <CityNm>ROCKVILLE</CityNm>
        <StateAbbreviationCd>MD</StateAbbreviationCd>
        <ZIPCd>20852</ZIPCd>
      </PreparerUSAddress>
    </PreparerFirmGrp>
    <ReturnTypeCd>990</ReturnTypeCd>
    <TaxPeriodBeginDt>2018-01-01</TaxPeriodBeginDt>
    <Filer>
      <EIN>311671642</EIN>
      <BusinessName>
        <BusinessNameLine1Txt>ASSOCIATION FOR MOLECULAR PATHOLOGY INC</BusinessNameLine1Txt>
      </BusinessName>
      <BusinessNameControlTxt>ASSO</BusinessNameControlTxt>
      <PhoneNum>3016347987</PhoneNum>
      <USAddress>
        <AddressLine1Txt>6120 EXECUTIVE BLVD SUITE 700</AddressLine1Txt>
        <CityNm>ROCKVILLE</CityNm>
        <StateAbbreviationCd>MD</StateAbbreviationCd>
        <ZIPCd>20852</ZIPCd>
      </USAddress>
    </Filer>
    <BusinessOfficerGrp>
      <PersonNm>MARY STEELE WILLIAMS</PersonNm>
      <PersonTitleTxt>EXECUTIVE DIRECTOR</PersonTitleTxt>
      <PhoneNum>3016347987</PhoneNum>
      <SignatureDt>2019-11-15</SignatureDt>
      <DiscussWithPaidPreparerInd>1</DiscussWithPaidPreparerInd>
    </BusinessOfficerGrp>
    <PreparerPersonGrp>
      <PreparerPersonNm>RAYMOND BARBAGALLO</PreparerPersonNm>
      <PTIN>P00173692</PTIN>
      <PhoneNum>3015899000</PhoneNum>
    </PreparerPersonGrp>
    <FilingSecurityInformation>
      <IPAddress>
        <IPv4AddressTxt>50.76.6.125</IPv4AddressTxt>
      </IPAddress>
      <IPDt>2019-11-15</IPDt>
      <IPTm>10:53:27</IPTm>
      <IPTimezoneCd>ES</IPTimezoneCd>
      <FilingLicenseTypeCd>P</FilingLicenseTypeCd>
      <AtSubmissionCreationDeviceId>DA39A3EE5E6B4B0D3255BFEF95601890AFD80709</AtSubmissionCreationDeviceId>
      <AtSubmissionFilingDeviceId>2DF66D12B427748EA1D905593407B360F81CECD2</AtSubmissionFilingDeviceId>
    </FilingSecurityInformation>
    <TaxYr>2018</TaxYr>
    <BuildTS>2020-03-31 21:24:44Z</BuildTS>
  </ReturnHeader>
  <ReturnData documentCnt="9">
    <IRS990 documentId="RetDoc1038000001" referenceDocumentId="RetDoc1044400001">
      <PrincipalOfficerNm>MARY STEELE WILLIAMS</PrincipalOfficerNm>
      <USAddress>
        <AddressLine1Txt>6120 EXECUTIVE BLVD SUITE 700</AddressLine1Txt>
        <CityNm>ROCKVILLE</CityNm>
        <StateAbbreviationCd>MD</StateAbbreviationCd>
        <ZIPCd>20852</ZIPCd>
      </USAddress>
      <GrossReceiptsAmt>5985958</GrossReceiptsAmt>
      <GroupReturnForAffiliatesInd>0</GroupReturnForAffiliatesInd>
      <Organization501c3Ind>X</Organization501c3Ind>
      <WebsiteAddressTxt>WWW.AMP.ORG</WebsiteAddressTxt>
      <TypeOfOrganizationCorpInd>X</TypeOfOrganizationCorpInd>
      <FormationYr>1999</FormationYr>
      <LegalDomicileStateCd>MD</LegalDomicileStateCd>
      <ActivityOrMissionDesc>ADVANCES THE CLINICAL PRACTICE, SCIENCE, AND EXCELLENCE OF MOLECULAR AND GENOMIC LABORATORY MEDICINE THROUGH EDUCATION, INNOVATION, AND ADVOCACY TO ENABLE HIGHEST QUALITY HEALTH CARE.</ActivityOrMissionDesc>
      <VotingMembersGoverningBodyCnt>16</VotingMembersGoverningBodyCnt>
      <VotingMembersIndependentCnt>16</VotingMembersIndependentCnt>
      <TotalEmployeeCnt>16</TotalEmployeeCnt>
      <TotalVolunteersCnt>180</TotalVolunteersCnt>
      <TotalGrossUBIAmt>0</TotalGrossUBIAmt>
      <NetUnrelatedBusTxblIncmAmt>0</NetUnrelatedBusTxblIncmAmt>
      <PYContributionsGrantsAmt>479220</PYContributionsGrantsAmt>
      <CYContributionsGrantsAmt>993430</CYContributionsGrantsAmt>
      <PYProgramServiceRevenueAmt>4280625</PYProgramServiceRevenueAmt>
      <CYProgramServiceRevenueAmt>4813271</CYProgramServiceRevenueAmt>
      <PYInvestmentIncomeAmt>121202</PYInvestmentIncomeAmt>
      <CYInvestmentIncomeAmt>170020</CYInvestmentIncomeAmt>
      <PYOtherRevenueAmt>3036</PYOtherRevenueAmt>
      <CYOtherRevenueAmt>9237</CYOtherRevenueAmt>
      <PYTotalRevenueAmt>4884083</PYTotalRevenueAmt>
      <CYTotalRevenueAmt>5985958</CYTotalRevenueAmt>
      <PYGrantsAndSimilarPaidAmt>31020</PYGrantsAndSimilarPaidAmt>
      <CYGrantsAndSimilarPaidAmt>36375</CYGrantsAndSimilarPaidAmt>
      <PYBenefitsPaidToMembersAmt>0</PYBenefitsPaidToMembersAmt>
      <CYBenefitsPaidToMembersAmt>0</CYBenefitsPaidToMembersAmt>
      <PYSalariesCompEmpBnftPaidAmt>1770378</PYSalariesCompEmpBnftPaidAmt>
      <CYSalariesCompEmpBnftPaidAmt>1954486</CYSalariesCompEmpBnftPaidAmt>
      <PYTotalProfFndrsngExpnsAmt>0</PYTotalProfFndrsngExpnsAmt>
      <CYTotalProfFndrsngExpnsAmt>0</CYTotalProfFndrsngExpnsAmt>
      <CYTotalFundraisingExpenseAmt>0</CYTotalFundraisingExpenseAmt>
      <PYOtherExpensesAmt>2277689</PYOtherExpensesAmt>
      <CYOtherExpensesAmt>3060092</CYOtherExpensesAmt>
      <PYTotalExpensesAmt>4079087</PYTotalExpensesAmt>
      <CYTotalExpensesAmt>5050953</CYTotalExpensesAmt>
      <PYRevenuesLessExpensesAmt>804996</PYRevenuesLessExpensesAmt>
      <CYRevenuesLessExpensesAmt>935005</CYRevenuesLessExpensesAmt>
      <TotalAssetsBOYAmt>10869927</TotalAssetsBOYAmt>
      <TotalAssetsEOYAmt>13414564</TotalAssetsEOYAmt>
      <TotalLiabilitiesBOYAmt>1052404</TotalLiabilitiesBOYAmt>
      <TotalLiabilitiesEOYAmt>3098733</TotalLiabilitiesEOYAmt>
      <NetAssetsOrFundBalancesBOYAmt>9817523</NetAssetsOrFundBalancesBOYAmt>
      <NetAssetsOrFundBalancesEOYAmt>10315831</NetAssetsOrFundBalancesEOYAmt>
      <InfoInScheduleOPartIIIInd>X</InfoInScheduleOPartIIIInd>
      <MissionDesc>ADVANCES THE CLINICAL PRACTICE, SCIENCE, AND EXCELLENCE OF MOLECULAR AND GENOMIC LABORATORY MEDICINE THROUGH EDUCATION, INNOVATION, AND ADVOCACY TO ENABLE HIGHEST QUALITY HEALTH CARE.</MissionDesc>
      <SignificantNewProgramSrvcInd>0</SignificantNewProgramSrvcInd>
      <SignificantChangeInd>0</SignificantChangeInd>
      <ExpenseAmt>2750628</ExpenseAmt>
      <GrantAmt>36375</GrantAmt>
      <RevenueAmt>4743449</RevenueAmt>
      <Desc>EDUCATION - SEE SCHEDULE O FOR COMPLETE DESCRIPTIONSCIENTIFIC SYMPOSIA AND MEETINGSTHE ORGANIZATION BRINGS TOGETHER SCIENTISTS FOR THE PROMOTION OF CLINICAL PRACTICE, BASIC RESEARCH, AND EDUCATION IN MOLECULAR PATHOLOGY.THIS YEAR, THE 24TH ANNUAL MEETING WAS HELD IN SAN ANTONIO, TEXAS. THIS THREE-DAY EVENT FEATURED MORE THAN 25 HOURS OF CUTTING-EDGE SESSIONS, A KEYNOTE PRESENTATION BY THE AMP 2018 AWARD FOR EXCELLENCE RECIPIENT, MORE THAN 459 POSTERS, 190 EXHIBITORS, AND COUNTLESS OPPORTUNITIES TO INTERACT DIRECTLY WITH COLLEAGUES. THERE WERE 2,106 REGISTRANTS AND 116 SPEAKERS.AMP PUTS ON A MOLECULAR COURSE FOR COMMUNITY PATHOLOGISTS CALLED THE MOLECULAR PATHOLOGY OUTREACH COURSE - AMPLICONS: A PRACTICAL MOLECULAR TOOLKIT AND CASE STUDIES. SINCE NEW MODELS OF MEDICAL PRACTICE ARE EVOLVING WITH INCREASING ATTENTION TO THE MOLECULAR PATHOLOGY OF DISEASES, THE INTRODUCTION OF MOLECULAR TESTING INTO CLINICAL LABORATORIES HAS INCREASED OUR ABILITY TO PROVIDE NOVEL TYPES OF INFORMATION TO HEALTH CARE PROVIDERS. THIS COURSE PROVIDES AN OVERVIEW OF TECHNIQUES AND INSTRUMENTATION USED IN MOLECULAR TESTING FROM THE FRAMEWORK OF THE "MOLECULAR PATHOLOGY/MOLECULAR DIAGNOSTIC TOOLKIT." THE METHODOLOGIES AND TECHNOLOGIES THAT COMPRISE THIS TOOLKIT WERE INTRODUCED, FOLLOWED BY CASE DISCUSSIONS TO DEMONSTRATE HOW THESE TOOLS ARE EMPLOYED IN THE MOLECULAR TESTING LABORATORY. EMPHASIS WERE PLACED ON MOLECULAR TESTING IN THE AREAS OF CLINICAL GENETICS, SOLID TUMORS, HEMATOPATHOLOY, INFORMATICS AND INFECTIOUS DISEASES. THE APPLICATION OF NOVEL TECHNOLOGIES SUCH AS NEXT GENERATION SEQUENCING WERE HIGHLIGHTED.MOLECULAR GENETIC PATHOLOGY REVIEW COURSE - AMP HAD ITS FIRST MGP REVIEW COURSE IN 2007. IT THEN HAD A LIVE EVENT IN ODD YEARS 2009, 2011, 2013, 2015 AND 2017. THE 2017 LIVE EVENT WAS RECORDED AND OFFERED AS AN ONLINE COURSE IN 2018 WITH REVENUE ACCOUNTED FOR IN ONLINE EDUCATION. THE COURSE ITSELF FEATURES 3 1/2 DAYS OF INTENSE UPDATE AND REVIEW OF MOLECULAR DIAGNOSTICS THAT IS PRIMARILY FOCUSED ON PREPARATION FOR THE MOLECULAR GENETIC PATHOLOGY (MGP) SUBSPECIALTY CERTIFICATION EXAM, AS WELL AS OTHER CERTIFICATION EXAMS. PARTICIPANTS HAVE THE OPPORTUNITY TO LEARN DIRECTLY FROM RECOGNIZED EXPERTS IN MOLECULAR PATHOLOGY, MOST OF WHOM HOLD MGP CERTIFICATION. A SPECIAL FEATURE IS AN ONLINE PRE-TEST, WITH SPECIAL TEST DISCUSSION SESSIONS DURING THE COURSE.THE OBJECTIVES OF THE AMP MGP REVIEW COURSE ARE:- TO ASSIST ATTENDEES' PREPARATION FOR THE MGP SUBSPECIALTY CERTIFICATON EXAM (OFFERED JOINTLY BY THE AMERICAN BOARD OF PATHOLOGY AND THE AMERICAN BOARD OF MEDICAL GENETICS), AS WELL AS OTHER CERTIFICATION EXAMS IN MOLECULAR PATHOLOGY AND MOLECULAR GENETICS, AND - TO INCREASE BASIC AND APPLIED PATHOLOGY KNOWLEDGE, FOCUSING ON THE MOLECULAR PATHOGENEIS, DIAGNOSIS, PROGNOSIS AND TREATMENT OF DISEASE.TOPICS INCLUDE:- MOLECULAR TECHNIQUES AND LAB METHODS- NGS PLATFORMS AND INFORMATICS- IDENTITY TESTING: FORENSICS- HLA TRANSPLANT TESTING- INHERITED CONDITIONS- PHARMACOGENOMICS- CYTOGENETICS- MOLECULAR ONCOLOGY- MOLECULAR HEMATOPATHOLOGY- INFECTIOUS DISEASES, BACTERIAL AND VIRAL- QUALITY ASSURANCE AND LAB REGULATION- LAB MANAGEMENTDISCLAIMER: AMP MAKES NO GUARANTEE OR ASSURANCES THAT COMPLETION OF ITS COURSE OR PARTICIPATION IN ANY EDUCATIONAL ACTIVITY WILL IN ANY MANNER ENSURE A PASSING SCORE ON ANY CERTIFICATION EXAMINATION OR ACTIVITY POST-TEST, OR ACHIEVEMENT OF CERTIFICATION STATUS.THE AMP MOLECULAR GENETIC PATHOLOGY REVIEW COURSE, ONLINE AND FACE-TO-FACE, IS AN EDUCATIONAL PROGRAM PROVIDED BY THE ASSOCIATION FOR MOLECULAR PATHOLOGY, (AMP), AND IS NOT SPONSORED OR ENDORSED BY THE AMERICAN BOARD OF PATHOLOGY, (ABP), OR THE AMERICAN BOARD OF MEDICAL GENETICS, (ABMG).AMP EUROPE 2018 - THE INAUGURAL AMP EUROPE WAS HELD IN ROTTERDAM, THE NETHERLANDS, ON APRIL 30 - MAY 2, 2018, WITH 300 ATTENDEES, 30 EXHIBITORS, 18 EDUCATIONAL SESSIONS AND 60+ POSTERS. AWARDS WERE PRESENTED FOR TRAVEL, SUPPORT AND YOUNG INVESTIGATOR POSTER PRESENTATION.ONLINE EDUCATION - AMP LAUNCHED "AMPED", ITS ONLINE LEARNING MANAGEMENT SYSTEM IN 2018 WITH A LARGE SELECTION OF MOLECULAR PATHOLOGY OFFERINGS, INCLUDING WEBINARS, COURSES, AND MEETING HIGHLIGHTS. MOST OF THE OFFERINGS INCLUDE CONTINUING MEDICAL EDUCATION CREDITS FOR PHYSICIANS AND OTHER MEDICAL PROFESSIONALS.</Desc>
      <ProgSrvcAccomActy2Grp>
        <ExpenseAmt>125071</ExpenseAmt>
        <Desc>COMMUNICATION &amp; OUTREACH: MEMBERSHIP SERVICES - WEBSITE, NEWSLETTERS, ETC.PROMOTE GENERAL EFFECTIVENESS AND PROVIDE A FORUM FOR DISCUSSION AND A MEANS OF EXCHANGING INFORMATION.</Desc>
      </ProgSrvcAccomActy2Grp>
      <ProgSrvcAccomActy3Grp>
        <ExpenseAmt>320118</ExpenseAmt>
        <RevenueAmt>69822</RevenueAmt>
        <Desc>INNOVATION &amp; IMPROVED PATIENT CARE - SEE SCHEDULE O FOR COMPLETE DESCRIPTIONTHE JOURNAL OF MOLECULAR DIAGNOSTICSTHIS IS THE OFFICIAL JOURNAL OF AMP. THERE WERE SIX ISSUES. THESE ISSUES HAVE ORIGINAL, HIGH-QUALITY MANUSCRIPTS ON SCIENTIFIC ADVANCES IN THE TRANSLATION AND VALIDATION OF MOLECULAR DISCOVERIES IN MEDICINE INTO THE CLINICAL DIAGNOSTIC SETTING, AND THE DESCRIPTION AND APPLICATION OF TECHNOLOGICAL ADVANCES IN THE FIELD OF MOLECULAR DIAGNOSTIC MEDICINE.EVERY PUBLISHED MANUSCRIPT IS SCIENTIFICALLY PEER REVIEWED.JMD IS JOINTLY OWNED WITH THE AMERICAN SOCIETY FOR INVESTIGATIVE PATHOLOGY (ASIP) 94-6079945. STARTING IN 2011, ELSEVIER BEGAN PUBLISHING JMD.TEST DIRECTORY - AMP MAINTAINS THIS DIRECTORY AS A SERVICE TO ITS MEMBERS AND THE PUBLIC. AMP MEMBERS VOLUNTARILY LIST THEIR LABORATORIES AND RESEARCH OR CLINICAL MOLECULAR TESTS FOR INCLUSION IN THIS DIRECTORY. THE AMP TEST DIRECTORY IS NOT A COMPREHENSIVE LIST OF MEMBERS WHOSE LABORATORIES PROVIDE TESTING. THIS INFORMATION IS AVAILABLE TO IDENTIFY LABORATORIES THAT MIGHT SERVE A GIVEN NEED. ALL INFORMATION IS COPYRIGHT PROTECTED AND THE INFORMATION CONTAINED HEREIN IS NOT TO BE USED FOR COMMERCIAL PURPOSES.</Desc>
      </ProgSrvcAccomActy3Grp>
      <ProgSrvcAccomActyOtherGrp>
        <ExpenseAmt>490772</ExpenseAmt>
        <Desc>ADVOCACYTHE AMP ADVOCACY PROGRAM ENDEAVORS TO INFORM AND INFLUENCE PUBLIC POLICY AFFECTING MOLECULAR PATHOLOGY. AMP REPRESENTS ITS MEMBERSHIP TO THE FEDERAL AGENCIES AND MEMBERS OF CONGRESS REGARDING PROFESSIONAL AND REIMBURSEMENT ISSUES - REACHING OUT TO FELLOW PROFESSIONAL ASSOCIATIONS, INDUSTRY AND OTHER ASSOCIATION PARTNERS TO ACCOMPLISH COMMON GOALS.</Desc>
      </ProgSrvcAccomActyOtherGrp>
      <TotalOtherProgSrvcExpenseAmt>490772</TotalOtherProgSrvcExpenseAmt>
      <TotalProgramServiceExpensesAmt>3686589</TotalProgramServiceExpensesAmt>
      <DescribedInSection501c3Ind referenceDocumentId="RetDoc1039100001">1</DescribedInSection501c3Ind>
      <ScheduleBRequiredInd referenceDocumentId="RetDoc1234500001">1</ScheduleBRequiredInd>
      <PoliticalCampaignActyInd referenceDocumentId="RetDoc1039600001">0</PoliticalCampaignActyInd>
      <LobbyingActivitiesInd referenceDocumentId="RetDoc1039600001">1</LobbyingActivitiesInd>
      <SubjectToProxyTaxInd referenceDocumentId="RetDoc1039600001">0</SubjectToProxyTaxInd>
      <DonorAdvisedFundInd referenceDocumentId="RetDoc1040000001">0</DonorAdvisedFundInd>
      <ConservationEasementsInd referenceDocumentId="RetDoc1040000001">0</ConservationEasementsInd>
      <CollectionsOfArtInd referenceDocumentId="RetDoc1040000001">0</CollectionsOfArtInd>
      <CreditCounselingInd referenceDocumentId="RetDoc1040000001">0</CreditCounselingInd>
      <TempOrPermanentEndowmentsInd referenceDocumentId="RetDoc1040000001">0</TempOrPermanentEndowmentsInd>
      <ReportLandBuildingEquipmentInd referenceDocumentId="RetDoc1040000001">1</ReportLandBuildingEquipmentInd>
      <ReportInvestmentsOtherSecInd referenceDocumentId="RetDoc1040000001">0</ReportInvestmentsOtherSecInd>
      <ReportProgramRelatedInvstInd referenceDocumentId="RetDoc1040000001">0</ReportProgramRelatedInvstInd>
      <ReportOtherAssetsInd referenceDocumentId="RetDoc1040000001">0</ReportOtherAssetsInd>
      <ReportOtherLiabilitiesInd referenceDocumentId="RetDoc1040000001">1</ReportOtherLiabilitiesInd>
      <IncludeFIN48FootnoteInd referenceDocumentId="RetDoc1040000001">1</IncludeFIN48FootnoteInd>
      <IndependentAuditFinclStmtInd referenceDocumentId="RetDoc1040000001">1</IndependentAuditFinclStmtInd>
      <ConsolidatedAuditFinclStmtInd referenceDocumentId="RetDoc1040000001">0</ConsolidatedAuditFinclStmtInd>
      <SchoolOperatingInd>0</SchoolOperatingInd>
      <ForeignOfficeInd>0</ForeignOfficeInd>
      <ForeignActivitiesInd referenceDocumentId="RetDoc1040500001">1</ForeignActivitiesInd>
      <MoreThan5000KToOrgInd referenceDocumentId="RetDoc1040500001">0</MoreThan5000KToOrgInd>
      <MoreThan5000KToIndividualsInd referenceDocumentId="RetDoc1040500001">1</MoreThan5000KToIndividualsInd>
      <ProfessionalFundraisingInd>0</ProfessionalFundraisingInd>
      <FundraisingActivitiesInd>0</FundraisingActivitiesInd>
      <GamingActivitiesInd>0</GamingActivitiesInd>
      <OperateHospitalInd>0</OperateHospitalInd>
      <GrantsToOrganizationsInd referenceDocumentId="RetDoc1041900001">0</GrantsToOrganizationsInd>
      <GrantsToIndividualsInd referenceDocumentId="RetDoc1041900001">1</GrantsToIndividualsInd>
      <ScheduleJRequiredInd referenceDocumentId="RetDoc1042400001">1</ScheduleJRequiredInd>
      <TaxExemptBondsInd>0</TaxExemptBondsInd>
      <EngagedInExcessBenefitTransInd>0</EngagedInExcessBenefitTransInd>
      <PYExcessBenefitTransInd>0</PYExcessBenefitTransInd>
      <LoanOutstandingInd>0</LoanOutstandingInd>
      <GrantToRelatedPersonInd>0</GrantToRelatedPersonInd>
      <BusinessRlnWithOrgMemInd>0</BusinessRlnWithOrgMemInd>
      <BusinessRlnWithFamMemInd>0</BusinessRlnWithFamMemInd>
      <BusinessRlnWithOfficerEntInd>0</BusinessRlnWithOfficerEntInd>
      <DeductibleNonCashContriInd>0</DeductibleNonCashContriInd>
      <DeductibleArtContributionInd>0</DeductibleArtContributionInd>
      <TerminateOperationsInd>0</TerminateOperationsInd>
      <PartialLiquidationInd>0</PartialLiquidationInd>
      <DisregardedEntityInd>0</DisregardedEntityInd>
      <RelatedEntityInd>0</RelatedEntityInd>
      <RelatedOrganizationCtrlEntInd>0</RelatedOrganizationCtrlEntInd>
      <TrnsfrExmptNonChrtblRltdOrgInd>0</TrnsfrExmptNonChrtblRltdOrgInd>
      <ActivitiesConductedPrtshpInd>0</ActivitiesConductedPrtshpInd>
      <ScheduleORequiredInd>1</ScheduleORequiredInd>
      <IRPDocumentCnt>35</IRPDocumentCnt>
      <IRPDocumentW2GCnt>0</IRPDocumentW2GCnt>
      <BackupWthldComplianceInd>1</BackupWthldComplianceInd>
      <EmployeeCnt>16</EmployeeCnt>
      <EmploymentTaxReturnsFiledInd>1</EmploymentTaxReturnsFiledInd>
      <UnrelatedBusIncmOverLimitInd>0</UnrelatedBusIncmOverLimitInd>
      <ForeignFinancialAccountInd>0</ForeignFinancialAccountInd>
      <ProhibitedTaxShelterTransInd>0</ProhibitedTaxShelterTransInd>
      <TaxablePartyNotificationInd>0</TaxablePartyNotificationInd>
      <NondeductibleContributionsInd>0</NondeductibleContributionsInd>
      <QuidProQuoContributionsInd>0</QuidProQuoContributionsInd>
      <Form8282PropertyDisposedOfInd>0</Form8282PropertyDisposedOfInd>
      <RcvFndsToPayPrsnlBnftCntrctInd>0</RcvFndsToPayPrsnlBnftCntrctInd>
      <PayPremiumsPrsnlBnftCntrctInd>0</PayPremiumsPrsnlBnftCntrctInd>
      <IndoorTanningServicesInd>0</IndoorTanningServicesInd>
      <SubjToTaxRmnrtnExPrchtPymtInd>0</SubjToTaxRmnrtnExPrchtPymtInd>
      <SubjectToExcsTaxNetInvstIncInd>0</SubjectToExcsTaxNetInvstIncInd>
      <InfoInScheduleOPartVIInd>X</InfoInScheduleOPartVIInd>
      <GoverningBodyVotingMembersCnt>16</GoverningBodyVotingMembersCnt>
      <IndependentVotingMemberCnt>16</IndependentVotingMemberCnt>
      <FamilyOrBusinessRlnInd>0</FamilyOrBusinessRlnInd>
      <DelegationOfMgmtDutiesInd>0</DelegationOfMgmtDutiesInd>
      <ChangeToOrgDocumentsInd>0</ChangeToOrgDocumentsInd>
      <MaterialDiversionOrMisuseInd>0</MaterialDiversionOrMisuseInd>
      <MembersOrStockholdersInd>1</MembersOrStockholdersInd>
      <ElectionOfBoardMembersInd>1</ElectionOfBoardMembersInd>
      <DecisionsSubjectToApprovaInd>0</DecisionsSubjectToApprovaInd>
      <MinutesOfGoverningBodyInd>1</MinutesOfGoverningBodyInd>
      <MinutesOfCommitteesInd>1</MinutesOfCommitteesInd>
      <OfficerMailingAddressInd>0</OfficerMailingAddressInd>
      <LocalChaptersInd>0</LocalChaptersInd>
      <Form990ProvidedToGvrnBodyInd>1</Form990ProvidedToGvrnBodyInd>
      <ConflictOfInterestPolicyInd>1</ConflictOfInterestPolicyInd>
      <AnnualDisclosureCoveredPrsnInd>1</AnnualDisclosureCoveredPrsnInd>
      <RegularMonitoringEnfrcInd>1</RegularMonitoringEnfrcInd>
      <WhistleblowerPolicyInd>1</WhistleblowerPolicyInd>
      <DocumentRetentionPolicyInd>1</DocumentRetentionPolicyInd>
      <CompensationProcessCEOInd>1</CompensationProcessCEOInd>
      <CompensationProcessOtherInd>0</CompensationProcessOtherInd>
      <InvestmentInJointVentureInd>0</InvestmentInJointVentureInd>
      <UponRequestInd>X</UponRequestInd>
      <BooksInCareOfDetail>
        <BusinessName>
          <BusinessNameLine1Txt>ASSOCIATION FOR MOLECULAR PATHOLOGY INC</BusinessNameLine1Txt>
        </BusinessName>
        <PhoneNum>3016347987</PhoneNum>
        <USAddress>
          <AddressLine1Txt>6120 EXECUTIVE BLVD SUITE 700</AddressLine1Txt>
          <CityNm>ROCKVILLE</CityNm>
          <StateAbbreviationCd>MD</StateAbbreviationCd>
          <ZIPCd>20852</ZIPCd>
        </USAddress>
      </BooksInCareOfDetail>
      <Form990PartVIISectionAGrp>
        <PersonNm>KOJO S J ELENITOBA-JOHNSON MD</PersonNm>
        <TitleTxt>PRESIDENT</TitleTxt>
        <AverageHoursPerWeekRt>2.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>FEDERICO A MONZON MD</PersonNm>
        <TitleTxt>PAST PRESIDENT</TitleTxt>
        <AverageHoursPerWeekRt>2.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>VICTORIA M PRATT PHD</PersonNm>
        <TitleTxt>PRESIDENT-ELECT</TitleTxt>
        <AverageHoursPerWeekRt>2.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>DANIEL E SABATH MD PHD</PersonNm>
        <TitleTxt>SECRETARY-TREASURER</TitleTxt>
        <AverageHoursPerWeekRt>2.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>RON M PRZYGODZKI MD</PersonNm>
        <TitleTxt>MEMBERSHIP AFFAIRS COMMITT</TitleTxt>
        <AverageHoursPerWeekRt>2.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>JORDAN LASER MD</PersonNm>
        <TitleTxt>PROFESSIONAL RELATIONS COM</TitleTxt>
        <AverageHoursPerWeekRt>2.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>CECILIA CS YEUNG MD</PersonNm>
        <TitleTxt>TRAINING &amp; EDUCATION COMM</TitleTxt>
        <AverageHoursPerWeekRt>2.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>DAVID R HILLYARD MD</PersonNm>
        <TitleTxt>INFECTIOUS DISEASES SUBDIV</TitleTxt>
        <AverageHoursPerWeekRt>2.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>ANTONIA R SEPULVEDA MD PHD</PersonNm>
        <TitleTxt>CLNICAL PRACTICE COMMITTEE</TitleTxt>
        <AverageHoursPerWeekRt>2.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>BIRGIT FUNKE PHD</PersonNm>
        <TitleTxt>GENETICS SUBDIVISION CHAIR</TitleTxt>
        <AverageHoursPerWeekRt>2.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>ALEXIS B CARTER MD</PersonNm>
        <TitleTxt>INFORMATICS SUBDIVISION CH</TitleTxt>
        <AverageHoursPerWeekRt>2.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>SAMUEL K CAUGHRON MD</PersonNm>
        <TitleTxt>ECONOMIC AFFAIRS COMMITTEE</TitleTxt>
        <AverageHoursPerWeekRt>2.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>LYNNE V ABRUZZO MD PHD</PersonNm>
        <TitleTxt>PROGRAM COMMITTEE CHAIR</TitleTxt>
        <AverageHoursPerWeekRt>2.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>PAUL G ROTHBERG PHD</PersonNm>
        <TitleTxt>PUBLICATION/COMMUNICATION</TitleTxt>
        <AverageHoursPerWeekRt>2.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>ANNETTE KIM MD PHD</PersonNm>
        <TitleTxt>HEMATOPATHOLOGY SUBDIVISIO</TitleTxt>
        <AverageHoursPerWeekRt>2.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>ROGER D KLEIN MD JD</PersonNm>
        <TitleTxt>SOLID TUMORS SUBDIVISION C</TitleTxt>
        <AverageHoursPerWeekRt>2.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>MARY STEELE WILLIAMS MNA MT ASCPSM</PersonNm>
        <TitleTxt>EXECUTIVE DIRECTOR</TitleTxt>
        <AverageHoursPerWeekRt>40.00</AverageHoursPerWeekRt>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>254012</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>45374</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>ROBYN TEMPLE-SMOLKIN</PersonNm>
        <TitleTxt>DIR CLINICAL/SCIENTIFIC AF</TitleTxt>
        <AverageHoursPerWeekRt>40.00</AverageHoursPerWeekRt>
        <HighestCompensatedEmployeeInd>X</HighestCompensatedEmployeeInd>
        <ReportableCompFromOrgAmt>128295</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>13447</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>LAUREN S MENSER</PersonNm>
        <TitleTxt>DIRECTOR OF STRATEGIC DEVE</TitleTxt>
        <AverageHoursPerWeekRt>40.00</AverageHoursPerWeekRt>
        <HighestCompensatedEmployeeInd>X</HighestCompensatedEmployeeInd>
        <ReportableCompFromOrgAmt>125859</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>20373</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>SARA HAMILTON</PersonNm>
        <TitleTxt>DIRECTOR OF MEETINGS &amp; EXH</TitleTxt>
        <AverageHoursPerWeekRt>40.00</AverageHoursPerWeekRt>
        <HighestCompensatedEmployeeInd>X</HighestCompensatedEmployeeInd>
        <ReportableCompFromOrgAmt>112124</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>19200</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>TARA BURKE</PersonNm>
        <TitleTxt>SR. DIRECTOR, PUBLIC POLIC</TitleTxt>
        <AverageHoursPerWeekRt>40.00</AverageHoursPerWeekRt>
        <HighestCompensatedEmployeeInd>X</HighestCompensatedEmployeeInd>
        <ReportableCompFromOrgAmt>153437</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>22010</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>LUCIA BARKER</PersonNm>
        <TitleTxt>DIRECTOR, EDUCATION PROGRAMS</TitleTxt>
        <AverageHoursPerWeekRt>40.00</AverageHoursPerWeekRt>
        <HighestCompensatedEmployeeInd>X</HighestCompensatedEmployeeInd>
        <ReportableCompFromOrgAmt>129206</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>20715</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <TotalReportableCompFromOrgAmt>902933</TotalReportableCompFromOrgAmt>
      <TotReportableCompRltdOrgAmt>0</TotReportableCompRltdOrgAmt>
      <TotalOtherCompensationAmt>141119</TotalOtherCompensationAmt>
      <IndivRcvdGreaterThan100KCnt>6</IndivRcvdGreaterThan100KCnt>
      <FormerOfcrEmployeesListedInd>0</FormerOfcrEmployeesListedInd>
      <TotalCompGreaterThan150KInd>1</TotalCompGreaterThan150KInd>
      <CompensationFromOtherSrcsInd>0</CompensationFromOtherSrcsInd>
      <ContractorCompensationGrp>
        <ContractorName>
          <BusinessName>
            <BusinessNameLine1Txt>THE RK CULINARY GROUP LLC</BusinessNameLine1Txt>
          </BusinessName>
        </ContractorName>
        <ContractorAddress>
          <USAddress>
            <AddressLine1Txt>900 E MARKET STREET</AddressLine1Txt>
            <CityNm>SAN ANTONIO</CityNm>
            <StateAbbreviationCd>TX</StateAbbreviationCd>
            <ZIPCd>78205</ZIPCd>
          </USAddress>
        </ContractorAddress>
        <ServicesDesc>FOOD &amp; BEVERAGE FOR ANNUAL MEETING</ServicesDesc>
        <CompensationAmt>396189</CompensationAmt>
      </ContractorCompensationGrp>
      <ContractorCompensationGrp>
        <ContractorName>
          <BusinessName>
            <BusinessNameLine1Txt>FREEMAN AUDIO VISUAL INC</BusinessNameLine1Txt>
          </BusinessName>
        </ContractorName>
        <ContractorAddress>
          <USAddress>
            <AddressLine1Txt>PO BOX 650519</AddressLine1Txt>
            <CityNm>DALLAS</CityNm>
            <StateAbbreviationCd>TX</StateAbbreviationCd>
            <ZIPCd>752650519</ZIPCd>
          </USAddress>
        </ContractorAddress>
        <ServicesDesc>EVENT TECHNOLOGY</ServicesDesc>
        <CompensationAmt>251802</CompensationAmt>
      </ContractorCompensationGrp>
      <ContractorCompensationGrp>
        <ContractorName>
          <BusinessName>
            <BusinessNameLine1Txt>CAVAROCCHI RUSCIO DENNIS ASSOC</BusinessNameLine1Txt>
          </BusinessName>
        </ContractorName>
        <ContractorAddress>
          <USAddress>
            <AddressLine1Txt>600 MARYLAND AVENUE SUITE 835W</AddressLine1Txt>
            <CityNm>WASHINGTON</CityNm>
            <StateAbbreviationCd>DC</StateAbbreviationCd>
            <ZIPCd>20024</ZIPCd>
          </USAddress>
        </ContractorAddress>
        <ServicesDesc>GOVERNMENT RELATIONS</ServicesDesc>
        <CompensationAmt>235650</CompensationAmt>
      </ContractorCompensationGrp>
      <ContractorCompensationGrp>
        <ContractorName>
          <BusinessName>
            <BusinessNameLine1Txt>THE EXPO GROUP LP</BusinessNameLine1Txt>
          </BusinessName>
        </ContractorName>
        <ContractorAddress>
          <USAddress>
            <AddressLine1Txt>5931 CAMPUS CIRCLE DRIVE</AddressLine1Txt>
            <CityNm>IRVING</CityNm>
            <StateAbbreviationCd>TX</StateAbbreviationCd>
            <ZIPCd>75063</ZIPCd>
          </USAddress>
        </ContractorAddress>
        <ServicesDesc>SERVICES/EQUIPMENT FOR ANNUAL MEETING</ServicesDesc>
        <CompensationAmt>158423</CompensationAmt>
      </ContractorCompensationGrp>
      <CntrctRcvdGreaterThan100KCnt>4</CntrctRcvdGreaterThan100KCnt>
      <MembershipDuesAmt>406550</MembershipDuesAmt>
      <AllOtherContributionsAmt>586880</AllOtherContributionsAmt>
      <TotalContributionsAmt>993430</TotalContributionsAmt>
      <ProgramServiceRevenueGrp>
        <Desc>EDUCATION</Desc>
        <BusinessCd>541900</BusinessCd>
        <TotalRevenueColumnAmt>4700449</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>4700449</RelatedOrExemptFuncIncomeAmt>
      </ProgramServiceRevenueGrp>
      <ProgramServiceRevenueGrp>
        <Desc>SHARE OF JMD NET INC</Desc>
        <BusinessCd>541900</BusinessCd>
        <TotalRevenueColumnAmt>54042</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>54042</RelatedOrExemptFuncIncomeAmt>
      </ProgramServiceRevenueGrp>
      <ProgramServiceRevenueGrp>
        <Desc>MAILING LIST RENTALS</Desc>
        <BusinessCd>541900</BusinessCd>
        <TotalRevenueColumnAmt>43000</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>43000</RelatedOrExemptFuncIncomeAmt>
      </ProgramServiceRevenueGrp>
      <ProgramServiceRevenueGrp>
        <Desc>JMD CME PROGRAM</Desc>
        <BusinessCd>541900</BusinessCd>
        <TotalRevenueColumnAmt>15780</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>15780</RelatedOrExemptFuncIncomeAmt>
      </ProgramServiceRevenueGrp>
      <TotalProgramServiceRevenueAmt>4813271</TotalProgramServiceRevenueAmt>
      <InvestmentIncomeGrp>
        <TotalRevenueColumnAmt>170020</TotalRevenueColumnAmt>
        <ExclusionAmt>170020</ExclusionAmt>
      </InvestmentIncomeGrp>
      <MiscellaneousRevenueGrp>
        <TotalRevenueColumnAmt>9237</TotalRevenueColumnAmt>
        <ExclusionAmt>9237</ExclusionAmt>
      </MiscellaneousRevenueGrp>
      <OtherRevenueTotalAmt>9237</OtherRevenueTotalAmt>
      <TotalRevenueGrp>
        <TotalRevenueColumnAmt>5985958</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>4813271</RelatedOrExemptFuncIncomeAmt>
        <UnrelatedBusinessRevenueAmt>0</UnrelatedBusinessRevenueAmt>
        <ExclusionAmt>179257</ExclusionAmt>
      </TotalRevenueGrp>
      <InfoInScheduleOPartIXInd>X</InfoInScheduleOPartIXInd>
      <GrantsToDomesticIndividualsGrp>
        <TotalAmt>16000</TotalAmt>
        <ProgramServicesAmt>16000</ProgramServicesAmt>
      </GrantsToDomesticIndividualsGrp>
      <ForeignGrantsGrp>
        <TotalAmt>20375</TotalAmt>
        <ProgramServicesAmt>20375</ProgramServicesAmt>
      </ForeignGrantsGrp>
      <CompCurrentOfcrDirectorsGrp>
        <TotalAmt>299386</TotalAmt>
        <ManagementAndGeneralAmt>299386</ManagementAndGeneralAmt>
      </CompCurrentOfcrDirectorsGrp>
      <OtherSalariesAndWagesGrp>
        <TotalAmt>1289577</TotalAmt>
        <ProgramServicesAmt>1144440</ProgramServicesAmt>
        <ManagementAndGeneralAmt>145137</ManagementAndGeneralAmt>
      </OtherSalariesAndWagesGrp>
      <PensionPlanContributionsGrp>
        <TotalAmt>130377</TotalAmt>
        <ProgramServicesAmt>114444</ProgramServicesAmt>
        <ManagementAndGeneralAmt>15933</ManagementAndGeneralAmt>
      </PensionPlanContributionsGrp>
      <OtherEmployeeBenefitsGrp>
        <TotalAmt>121547</TotalAmt>
        <ProgramServicesAmt>120854</ProgramServicesAmt>
        <ManagementAndGeneralAmt>693</ManagementAndGeneralAmt>
      </OtherEmployeeBenefitsGrp>
      <PayrollTaxesGrp>
        <TotalAmt>113599</TotalAmt>
        <ProgramServicesAmt>68132</ProgramServicesAmt>
        <ManagementAndGeneralAmt>45467</ManagementAndGeneralAmt>
      </PayrollTaxesGrp>
      <FeesForServicesLegalGrp>
        <TotalAmt>3437</TotalAmt>
        <ManagementAndGeneralAmt>3437</ManagementAndGeneralAmt>
      </FeesForServicesLegalGrp>
      <FeesForServicesAccountingGrp>
        <TotalAmt>56040</TotalAmt>
        <ManagementAndGeneralAmt>56040</ManagementAndGeneralAmt>
      </FeesForServicesAccountingGrp>
      <FeesForSrvcInvstMgmntFeesGrp>
        <TotalAmt>35178</TotalAmt>
        <ManagementAndGeneralAmt>35178</ManagementAndGeneralAmt>
      </FeesForSrvcInvstMgmntFeesGrp>
      <FeesForServicesOtherGrp>
        <TotalAmt>627920</TotalAmt>
        <ProgramServicesAmt>450010</ProgramServicesAmt>
        <ManagementAndGeneralAmt>177910</ManagementAndGeneralAmt>
      </FeesForServicesOtherGrp>
      <AdvertisingGrp>
        <TotalAmt>199260</TotalAmt>
        <ProgramServicesAmt>181338</ProgramServicesAmt>
        <ManagementAndGeneralAmt>17922</ManagementAndGeneralAmt>
      </AdvertisingGrp>
      <OfficeExpensesGrp>
        <TotalAmt>242826</TotalAmt>
        <ProgramServicesAmt>85591</ProgramServicesAmt>
        <ManagementAndGeneralAmt>157235</ManagementAndGeneralAmt>
      </OfficeExpensesGrp>
      <InformationTechnologyGrp>
        <TotalAmt>42078</TotalAmt>
        <ProgramServicesAmt>9704</ProgramServicesAmt>
        <ManagementAndGeneralAmt>32374</ManagementAndGeneralAmt>
      </InformationTechnologyGrp>
      <OccupancyGrp>
        <TotalAmt>319618</TotalAmt>
        <ProgramServicesAmt>93892</ProgramServicesAmt>
        <ManagementAndGeneralAmt>225726</ManagementAndGeneralAmt>
      </OccupancyGrp>
      <ConferencesMeetingsGrp>
        <TotalAmt>1425943</TotalAmt>
        <ProgramServicesAmt>1348306</ProgramServicesAmt>
        <ManagementAndGeneralAmt>77637</ManagementAndGeneralAmt>
      </ConferencesMeetingsGrp>
      <DepreciationDepletionGrp>
        <TotalAmt>27939</TotalAmt>
        <ManagementAndGeneralAmt>27939</ManagementAndGeneralAmt>
      </DepreciationDepletionGrp>
      <InsuranceGrp>
        <TotalAmt>27755</TotalAmt>
        <ProgramServicesAmt>13320</ProgramServicesAmt>
        <ManagementAndGeneralAmt>14435</ManagementAndGeneralAmt>
      </InsuranceGrp>
      <OtherExpensesGrp>
        <Desc>PROJECT SUPPORT</Desc>
        <TotalAmt>37277</TotalAmt>
        <ProgramServicesAmt>15171</ProgramServicesAmt>
        <ManagementAndGeneralAmt>22106</ManagementAndGeneralAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>CORPORATE PARTNERSHIPS</Desc>
        <TotalAmt>11821</TotalAmt>
        <ProgramServicesAmt>2012</ProgramServicesAmt>
        <ManagementAndGeneralAmt>9809</ManagementAndGeneralAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>GRASSROOTS COMMUNICATIO</Desc>
        <TotalAmt>3000</TotalAmt>
        <ProgramServicesAmt>3000</ProgramServicesAmt>
      </OtherExpensesGrp>
      <TotalFunctionalExpensesGrp>
        <TotalAmt>5050953</TotalAmt>
        <ProgramServicesAmt>3686589</ProgramServicesAmt>
        <ManagementAndGeneralAmt>1364364</ManagementAndGeneralAmt>
        <FundraisingAmt>0</FundraisingAmt>
      </TotalFunctionalExpensesGrp>
      <CashNonInterestBearingGrp>
        <BOYAmt>2709554</BOYAmt>
        <EOYAmt>2167651</EOYAmt>
      </CashNonInterestBearingGrp>
      <AccountsReceivableGrp>
        <BOYAmt>156114</BOYAmt>
        <EOYAmt>210769</EOYAmt>
      </AccountsReceivableGrp>
      <PrepaidExpensesDefrdChargesGrp>
        <BOYAmt>191977</BOYAmt>
        <EOYAmt>299005</EOYAmt>
      </PrepaidExpensesDefrdChargesGrp>
      <LandBldgEquipCostOrOtherBssAmt>258633</LandBldgEquipCostOrOtherBssAmt>
      <LandBldgEquipAccumDeprecAmt>110984</LandBldgEquipAccumDeprecAmt>
      <LandBldgEquipBasisNetGrp>
        <BOYAmt>72810</BOYAmt>
        <EOYAmt>147649</EOYAmt>
      </LandBldgEquipBasisNetGrp>
      <InvestmentsPubTradedSecGrp>
        <BOYAmt>7685074</BOYAmt>
        <EOYAmt>8383214</EOYAmt>
      </InvestmentsPubTradedSecGrp>
      <IntangibleAssetsGrp>
        <EOYAmt>2159478</EOYAmt>
      </IntangibleAssetsGrp>
      <OtherAssetsTotalGrp>
        <BOYAmt>54398</BOYAmt>
        <EOYAmt>46798</EOYAmt>
      </OtherAssetsTotalGrp>
      <TotalAssetsGrp>
        <BOYAmt>10869927</BOYAmt>
        <EOYAmt>13414564</EOYAmt>
      </TotalAssetsGrp>
      <AccountsPayableAccrExpnssGrp>
        <BOYAmt>439079</BOYAmt>
        <EOYAmt>363577</EOYAmt>
      </AccountsPayableAccrExpnssGrp>
      <DeferredRevenueGrp>
        <BOYAmt>613325</BOYAmt>
        <EOYAmt>412554</EOYAmt>
      </DeferredRevenueGrp>
      <OtherLiabilitiesGrp>
        <BOYAmt>0</BOYAmt>
        <EOYAmt>2322602</EOYAmt>
      </OtherLiabilitiesGrp>
      <TotalLiabilitiesGrp>
        <BOYAmt>1052404</BOYAmt>
        <EOYAmt>3098733</EOYAmt>
      </TotalLiabilitiesGrp>
      <OrganizationFollowsSFAS117Ind>X</OrganizationFollowsSFAS117Ind>
      <UnrestrictedNetAssetsGrp>
        <BOYAmt>9817523</BOYAmt>
        <EOYAmt>10122115</EOYAmt>
      </UnrestrictedNetAssetsGrp>
      <TemporarilyRstrNetAssetsGrp>
        <EOYAmt>193716</EOYAmt>
      </TemporarilyRstrNetAssetsGrp>
      <TotalNetAssetsFundBalanceGrp>
        <BOYAmt>9817523</BOYAmt>
        <EOYAmt>10315831</EOYAmt>
      </TotalNetAssetsFundBalanceGrp>
      <TotLiabNetAssetsFundBalanceGrp>
        <BOYAmt>10869927</BOYAmt>
        <EOYAmt>13414564</EOYAmt>
      </TotLiabNetAssetsFundBalanceGrp>
      <ReconcilationRevenueExpnssAmt>935005</ReconcilationRevenueExpnssAmt>
      <NetUnrlzdGainsLossesInvstAmt>-436697</NetUnrlzdGainsLossesInvstAmt>
      <OtherChangesInNetAssetsAmt>0</OtherChangesInNetAssetsAmt>
      <MethodOfAccountingAccrualInd>X</MethodOfAccountingAccrualInd>
      <AccountantCompileOrReviewInd>0</AccountantCompileOrReviewInd>
      <FSAuditedInd>1</FSAuditedInd>
      <FSAuditedBasisGrp>
        <SeparateBasisFinclStmtInd>X</SeparateBasisFinclStmtInd>
      </FSAuditedBasisGrp>
      <AuditCommitteeInd>1</AuditCommitteeInd>
      <FederalGrantAuditRequiredInd>0</FederalGrantAuditRequiredInd>
    </IRS990>
    <IRS990ScheduleA documentId="RetDoc1039100001">
      <PubliclySupportedOrg509a2Ind>X</PubliclySupportedOrg509a2Ind>
      <GiftsGrantsContrisRcvd509Grp>
        <CurrentTaxYearMinus4YearsAmt>1145397</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>919140</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>919059</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>864665</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>993430</CurrentTaxYearAmt>
        <TotalAmt>4841691</TotalAmt>
      </GiftsGrantsContrisRcvd509Grp>
      <GrossReceiptsAdmissionsGrp>
        <CurrentTaxYearMinus4YearsAmt>2994882</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>3777570</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>4150220</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>3898216</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>4822508</CurrentTaxYearAmt>
        <TotalAmt>19643396</TotalAmt>
      </GrossReceiptsAdmissionsGrp>
      <Total509Grp>
        <CurrentTaxYearMinus4YearsAmt>4140279</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>4696710</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>5069279</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>4762881</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>5815938</CurrentTaxYearAmt>
        <TotalAmt>24485087</TotalAmt>
      </Total509Grp>
      <AmountsRcvdDsqlfyPersonGrp>
        <TotalAmt>0</TotalAmt>
      </AmountsRcvdDsqlfyPersonGrp>
      <SubstantialContributorsAmtGrp>
        <TotalAmt>0</TotalAmt>
      </SubstantialContributorsAmtGrp>
      <SubstAndDsqlfyPrsnsTotGrp>
        <TotalAmt>0</TotalAmt>
      </SubstAndDsqlfyPrsnsTotGrp>
      <PublicSupportTotal509Amt>24485087</PublicSupportTotal509Amt>
      <GrossInvestmentIncome509Grp>
        <CurrentTaxYearMinus4YearsAmt>67021</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>73546</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>96906</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>121202</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>170020</CurrentTaxYearAmt>
        <TotalAmt>528695</TotalAmt>
      </GrossInvestmentIncome509Grp>
      <InvestmentIncomeAndUBTIGrp>
        <CurrentTaxYearMinus4YearsAmt>67021</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>73546</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>96906</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>121202</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>170020</CurrentTaxYearAmt>
        <TotalAmt>528695</TotalAmt>
      </InvestmentIncomeAndUBTIGrp>
      <TotalSupportCalendarYearGrp>
        <CurrentTaxYearMinus4YearsAmt>4207300</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>4770256</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>5166185</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>4884083</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>5985958</CurrentTaxYearAmt>
        <TotalAmt>25013782</TotalAmt>
      </TotalSupportCalendarYearGrp>
      <PublicSupportCY509Pct>0.97890</PublicSupportCY509Pct>
      <PublicSupportPY509Pct>0.96920</PublicSupportPY509Pct>
      <InvestmentIncomeCYPct>0.02110</InvestmentIncomeCYPct>
      <InvestmentIncomePYPct>0.03080</InvestmentIncomePYPct>
      <ThirtyThrPctSuprtTestsCY509Ind>X</ThirtyThrPctSuprtTestsCY509Ind>
    </IRS990ScheduleA>
    <IRS990ScheduleB documentId="RetDoc1234500001">
      <ContributorInformationGrp>
        <ContributorNum>RESTRICTED</ContributorNum>
        <ContributorBusinessName>
          <BusinessNameLine1>RESTRICTED</BusinessNameLine1>
        </ContributorBusinessName>
        <ContributorUSAddress>
          <AddressLine1>RESTRICTED</AddressLine1>
          <AddressLine2>RESTRICTED</AddressLine2>
          <City>RESTRICTED</City>
          <State>RESTRICTED</State>
          <ZIPCode>RESTRICTED</ZIPCode>
        </ContributorUSAddress>
        <TotalContributionsAmt>RESTRICTED</TotalContributionsAmt>
      </ContributorInformationGrp>
    </IRS990ScheduleB>
    <IRS990ScheduleC documentId="RetDoc1039600001">
      <TotalGrassrootsLobbyingGrp>
        <FilingOrganizationsTotalAmt>280</FilingOrganizationsTotalAmt>
      </TotalGrassrootsLobbyingGrp>
      <TotalDirectLobbyingGrp>
        <FilingOrganizationsTotalAmt>19314</FilingOrganizationsTotalAmt>
      </TotalDirectLobbyingGrp>
      <TotalLobbyingExpendGrp>
        <FilingOrganizationsTotalAmt>19594</FilingOrganizationsTotalAmt>
      </TotalLobbyingExpendGrp>
      <OtherExemptPurposeExpendGrp>
        <FilingOrganizationsTotalAmt>4996181</FilingOrganizationsTotalAmt>
      </OtherExemptPurposeExpendGrp>
      <TotalExemptPurposeExpendGrp>
        <FilingOrganizationsTotalAmt>5015775</FilingOrganizationsTotalAmt>
      </TotalExemptPurposeExpendGrp>
      <LobbyingNontaxableAmountGrp>
        <FilingOrganizationsTotalAmt>400789</FilingOrganizationsTotalAmt>
      </LobbyingNontaxableAmountGrp>
      <GrassrootsNontaxableGrp>
        <FilingOrganizationsTotalAmt>100197</FilingOrganizationsTotalAmt>
      </GrassrootsNontaxableGrp>
      <TotLbbyngGrassrootMnsNonTxGrp>
        <FilingOrganizationsTotalAmt>0</FilingOrganizationsTotalAmt>
      </TotLbbyngGrassrootMnsNonTxGrp>
      <TotLbbyExpendMnsLbbyngNonTxGrp>
        <FilingOrganizationsTotalAmt>0</FilingOrganizationsTotalAmt>
      </TotLbbyExpendMnsLbbyngNonTxGrp>
      <AvgLobbyingNontaxableAmountGrp>
        <CurrentYearMinus3Amt>319286</CurrentYearMinus3Amt>
        <CurrentYearMinus2Amt>339734</CurrentYearMinus2Amt>
        <CurrentYearMinus1Amt>353954</CurrentYearMinus1Amt>
        <CurrentYearAmt>400789</CurrentYearAmt>
        <TotalAmt>1413763</TotalAmt>
      </AvgLobbyingNontaxableAmountGrp>
      <LobbyingCeilingAmt>2120645</LobbyingCeilingAmt>
      <AvgTotalLobbyingExpendGrp>
        <CurrentYearMinus3Amt>30523</CurrentYearMinus3Amt>
        <CurrentYearMinus2Amt>18737</CurrentYearMinus2Amt>
        <CurrentYearMinus1Amt>5770</CurrentYearMinus1Amt>
        <CurrentYearAmt>19594</CurrentYearAmt>
        <TotalAmt>74624</TotalAmt>
      </AvgTotalLobbyingExpendGrp>
      <AvgGrassrootsNontaxableGrp>
        <CurrentYearMinus3Amt>79822</CurrentYearMinus3Amt>
        <CurrentYearMinus2Amt>84934</CurrentYearMinus2Amt>
        <CurrentYearMinus1Amt>88489</CurrentYearMinus1Amt>
        <CurrentYearAmt>100197</CurrentYearAmt>
        <TotalAmt>353442</TotalAmt>
      </AvgGrassrootsNontaxableGrp>
      <GrassrootsCeilingAmt>530163</GrassrootsCeilingAmt>
      <AvgGrassrootsLobbyingExpendGrp>
        <CurrentYearMinus3Amt>3158</CurrentYearMinus3Amt>
        <CurrentYearMinus2Amt>3048</CurrentYearMinus2Amt>
        <CurrentYearMinus1Amt>3000</CurrentYearMinus1Amt>
        <CurrentYearAmt>280</CurrentYearAmt>
        <TotalAmt>9486</TotalAmt>
      </AvgGrassrootsLobbyingExpendGrp>
    </IRS990ScheduleC>
    <IRS990ScheduleD documentId="RetDoc1040000001">
      <LeaseholdImprovementsGrp>
        <OtherCostOrOtherBasisAmt>13020</OtherCostOrOtherBasisAmt>
        <BookValueAmt>13020</BookValueAmt>
      </LeaseholdImprovementsGrp>
      <EquipmentGrp>
        <OtherCostOrOtherBasisAmt>245613</OtherCostOrOtherBasisAmt>
        <DepreciationAmt>110984</DepreciationAmt>
        <BookValueAmt>134629</BookValueAmt>
      </EquipmentGrp>
      <TotalBookValueLandBuildingsAmt>147649</TotalBookValueLandBuildingsAmt>
      <OtherLiabilitiesOrgGrp>
        <Desc>LEASE LIABILTY</Desc>
        <Amt>2322602</Amt>
      </OtherLiabilitiesOrgGrp>
      <TotalLiabilityAmt>2322602</TotalLiabilityAmt>
      <FootnoteTextInd>X</FootnoteTextInd>
      <TotalRevEtcAuditedFinclStmtAmt>5514083</TotalRevEtcAuditedFinclStmtAmt>
      <NetUnrealizedGainsInvstAmt>-436697</NetUnrealizedGainsInvstAmt>
      <RevenueNotReportedAmt>-436697</RevenueNotReportedAmt>
      <RevenueSubtotalAmt>5950780</RevenueSubtotalAmt>
      <InvestmentExpensesNotIncldAmt>35178</InvestmentExpensesNotIncldAmt>
      <RevenueNotReportedFinclStmtAmt>35178</RevenueNotReportedFinclStmtAmt>
      <TotalRevenuePerForm990Amt>5985958</TotalRevenuePerForm990Amt>
      <TotExpnsEtcAuditedFinclStmtAmt>5015775</TotExpnsEtcAuditedFinclStmtAmt>
      <ExpensesNotReportedAmt>0</ExpensesNotReportedAmt>
      <ExpensesSubtotalAmt>5015775</ExpensesSubtotalAmt>
      <InvestmentExpensesNotIncld2Amt>35178</InvestmentExpensesNotIncld2Amt>
      <ExpensesNotRptFinclStmtAmt>35178</ExpensesNotRptFinclStmtAmt>
      <TotalExpensesPerForm990Amt>5050953</TotalExpensesPerForm990Amt>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART X, LINE 2:</FormAndLineReferenceDesc>
        <ExplanationTxt>IN 2009, THE ASSOCIATION ADOPTED FASB INTERPRETATION NO. 48 (FIN 48) ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES, THAT CLARIFIES THE ACCOUNTING AND RECOGNITION FOR INCOME TAX POSITIONS TAKEN OR EXPECTED TO BE TAKEN IN THE ASSOCIATION'S INCOME TAX RETURNS. IN EVALUATING THE ASSOCIATION'S TAX PROVISIONS AND ACCRUALS, MANAGEMENT CONSIDERS FUTURE TAXABLE INCOME, THE REVERSAL OF TEMPORARY DIFFERENCES, INTERPRETATIONS, AND TAX PLANNING STRATEGIES. THE ASSOCIATION BELIEVES THEIR ESTIMATE IS APPROPRIATE BASED ON CURRENT FACTS AND CIRCUMSTANCES. THE ASSOCIATION'S TAX RETURNS ARE SUBJECT TO AUDIT BY THEIR RESPECTIVE TAXING AUTHORITIES FOR THE PRIOR THREE YEARS. THERE WAS NO IMPACT TO THE ASSOCIATION'S FINANCIAL STATEMENTS AS A RESULT OF THE IMPLEMENTATION OF FIN 48.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleD>
    <IRS990ScheduleF documentId="RetDoc1040500001">
      <GrantRecordsMaintainedInd>1</GrantRecordsMaintainedInd>
      <AccountActivitiesOutsideUSGrp>
        <RegionTxt>EUROPE (INCLUDING ICELAND &amp; GREENLAND)</RegionTxt>
        <OfficesCnt>0</OfficesCnt>
        <EmployeeCnt>0</EmployeeCnt>
        <TypeOfActivitiesConductedTxt>PROGRAM SERVICES</TypeOfActivitiesConductedTxt>
        <SpecificServicesProvidedTxt>AMP EUROPE 2018 - SEE PAGE 5 FOR COMPLETE DESCRIPTION.</SpecificServicesProvidedTxt>
        <RegionTotalExpendituresAmt>292272</RegionTotalExpendituresAmt>
      </AccountActivitiesOutsideUSGrp>
      <SubtotalOfficesCnt>0</SubtotalOfficesCnt>
      <SubtotalEmployeesCnt>0</SubtotalEmployeesCnt>
      <ContinuationTotalOfficeCnt>0</ContinuationTotalOfficeCnt>
      <ContinuationTotalEmployeeCnt>0</ContinuationTotalEmployeeCnt>
      <TotalOfficeCnt>0</TotalOfficeCnt>
      <TotalEmployeeCnt>0</TotalEmployeeCnt>
      <SubtotalSpentAmt>292272</SubtotalSpentAmt>
      <ContinuationSpentAmt>0</ContinuationSpentAmt>
      <TotalSpentAmt>292272</TotalSpentAmt>
      <ForeignIndividualsGrantsGrp>
        <TypeOfAssistanceTxt>INTERNATIONAL TRAINEE TRAVEL AWARD: TRAVEL ASSISTANCE TO AMP ANNUAL MEETING &amp; EXPO IN U.S. TO SELECTED INTERNATIONAL AMP MEMBER TRAINEES (RESIDENTS, FELLOWS, AND STUDENTS) RESIDING AND EMPLOYED OUTSIDE THE U.S. WHO DO NOT RECEIVE TRAVEL SUPPORT FROM THEIR INSTITUTIONS.</TypeOfAssistanceTxt>
        <RegionTxt>SOUTH AMERICA</RegionTxt>
        <RecipientCnt>1</RecipientCnt>
        <CashGrantAmt>3000</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK</MannerOfCashDisbursementTxt>
        <ValuationMethodUsedDesc>BOOK</ValuationMethodUsedDesc>
      </ForeignIndividualsGrantsGrp>
      <ForeignIndividualsGrantsGrp>
        <TypeOfAssistanceTxt>INTERNATIONAL TRAINEE TRAVEL AWARD: TRAVEL ASSISTANCE TO AMP ANNUAL MEETING &amp; EXPO IN U.S. TO SELECTED INTERNATIONAL AMP MEMBER TRAINEES (RESIDENTS, FELLOWS, AND STUDENTS) RESIDING AND EMPLOYED OUTSIDE THE U.S. WHO DO NOT RECEIVE TRAVEL SUPPORT FROM THEIR INSTITUTIONS.</TypeOfAssistanceTxt>
        <RegionTxt>SOUTH ASIA</RegionTxt>
        <RecipientCnt>1</RecipientCnt>
        <CashGrantAmt>3000</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK</MannerOfCashDisbursementTxt>
        <ValuationMethodUsedDesc>BOOK</ValuationMethodUsedDesc>
      </ForeignIndividualsGrantsGrp>
      <ForeignIndividualsGrantsGrp>
        <TypeOfAssistanceTxt>INTERNATIONAL TRAINEE TRAVEL AWARD: TRAVEL ASSISTANCE TO AMP ANNUAL MEETING &amp; EXPO IN U.S. TO SELECTED INTERNATIONAL AMP MEMBER TRAINEES (RESIDENTS, FELLOWS, AND STUDENTS) RESIDING AND EMPLOYED OUTSIDE THE U.S. WHO DO NOT RECEIVE TRAVEL SUPPORT FROM THEIR INSTITUTIONS.</TypeOfAssistanceTxt>
        <RegionTxt>EUROPE (INCLUDING ICELAND &amp; GREENLAND)</RegionTxt>
        <RecipientCnt>1</RecipientCnt>
        <CashGrantAmt>3000</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK</MannerOfCashDisbursementTxt>
        <ValuationMethodUsedDesc>BOOK</ValuationMethodUsedDesc>
      </ForeignIndividualsGrantsGrp>
      <ForeignIndividualsGrantsGrp>
        <TypeOfAssistanceTxt>GLOBAL IMPACT AWARD: TRAVEL ASSISTANCE TO AMP INTERNATIONAL MEETINGS FOR APPLICANTS FROM LOWER-MIDDLE AND LOW INCOME COUNTRIES.</TypeOfAssistanceTxt>
        <RegionTxt>SOUTH ASIA</RegionTxt>
        <RecipientCnt>1</RecipientCnt>
        <CashGrantAmt>3000</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK</MannerOfCashDisbursementTxt>
        <ValuationMethodUsedDesc>BOOK</ValuationMethodUsedDesc>
      </ForeignIndividualsGrantsGrp>
      <ForeignIndividualsGrantsGrp>
        <TypeOfAssistanceTxt>GLOBAL YOUNG INVESTIGATOR TRAVEL AWARD: TRAVEL ASSISTANCE TO THE AMP INTERNATIONAL MEETING TO HELP NURTURE THE NEXT GENERATION OF MOLECULAR PROFESSIONALS IN LABORATORY MEDICINE.</TypeOfAssistanceTxt>
        <RegionTxt>RUSSIA AND NEIGHBORING STATES</RegionTxt>
        <RecipientCnt>1</RecipientCnt>
        <CashGrantAmt>1000</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK</MannerOfCashDisbursementTxt>
        <ValuationMethodUsedDesc>BOOK</ValuationMethodUsedDesc>
      </ForeignIndividualsGrantsGrp>
      <ForeignIndividualsGrantsGrp>
        <TypeOfAssistanceTxt>GLOBAL YOUNG INVESTIGATOR TRAVEL AWARD: TRAVEL ASSISTANCE TO THE AMP INTERNATIONAL MEETING TO HELP NURTURE THE NEXT GENERATION OF MOLECULAR PROFESSIONALS IN LABORATORY MEDICINE.</TypeOfAssistanceTxt>
        <RegionTxt>SOUTH ASIA</RegionTxt>
        <RecipientCnt>1</RecipientCnt>
        <CashGrantAmt>1000</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK</MannerOfCashDisbursementTxt>
        <ValuationMethodUsedDesc>BOOK</ValuationMethodUsedDesc>
      </ForeignIndividualsGrantsGrp>
      <ForeignIndividualsGrantsGrp>
        <TypeOfAssistanceTxt>GLOBAL YOUNG INVESTIGATOR POSTER AWARD: RECOGNIZES THE BEST ABSTRACTS SUBMITTED BY TRAINEES OR EARLY CAREER TECHNICIANS OR LABORATORY SCIENTISTS WHO ARE FIRST AUTHORS AND WHO PRESENT OUTSTANDING BASIC OR APPLIED RESEARCH IN POSTER FORMAT. THIS AWARD IS ONLY OFFERED FOR THE AMP INTERNATIONAL MEETINGS.</TypeOfAssistanceTxt>
        <RegionTxt>EUROPE (INCLUDING ICELAND &amp; GREENLAND)</RegionTxt>
        <RecipientCnt>1</RecipientCnt>
        <CashGrantAmt>1000</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK</MannerOfCashDisbursementTxt>
        <ValuationMethodUsedDesc>BOOK</ValuationMethodUsedDesc>
      </ForeignIndividualsGrantsGrp>
      <ForeignIndividualsGrantsGrp>
        <TypeOfAssistanceTxt>GLOBAL YOUNG INVESTIGATOR POSTER AWARD: RECOGNIZES THE BEST ABSTRACTS SUBMITTED BY TRAINEES OR EARLY CAREER TECHNICIANS OR LABORATORY SCIENTISTS WHO ARE FIRST AUTHORS AND WHO PRESENT OUTSTANDING BASIC OR APPLIED RESEARCH IN POSTER FORMAT. THIS AWARD IS ONLY OFFERED FOR THE AMP INTERNATIONAL MEETINGS.</TypeOfAssistanceTxt>
        <RegionTxt>SOUTH ASIA</RegionTxt>
        <RecipientCnt>1</RecipientCnt>
        <CashGrantAmt>1000</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK</MannerOfCashDisbursementTxt>
        <ValuationMethodUsedDesc>BOOK</ValuationMethodUsedDesc>
      </ForeignIndividualsGrantsGrp>
      <ForeignIndividualsGrantsGrp>
        <TypeOfAssistanceTxt>GLOBAL YOUNG INVESTIGATOR POSTER AWARD: RECOGNIZES THE BEST ABSTRACTS SUBMITTED BY TRAINEES OR EARLY CAREER TECHNICIANS OR LABORATORY SCIENTISTS WHO ARE FIRST AUTHORS AND WHO PRESENT OUTSTANDING BASIC OR APPLIED RESEARCH IN POSTER FORMAT. THIS AWARD IS ONLY OFFERED FOR THE AMP INTERNATIONAL MEETINGS.</TypeOfAssistanceTxt>
        <RegionTxt>EUROPE (INCLUDING ICELAND &amp; GREENLAND)</RegionTxt>
        <RecipientCnt>1</RecipientCnt>
        <CashGrantAmt>1000</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK</MannerOfCashDisbursementTxt>
        <ValuationMethodUsedDesc>BOOK</ValuationMethodUsedDesc>
      </ForeignIndividualsGrantsGrp>
      <ForeignIndividualsGrantsGrp>
        <TypeOfAssistanceTxt>TECHNOLOGIST TRAVEL AWARD: TRAVEL ASSISTANCE TO THE AMP ANNUAL MEETING &amp; EXPO IN U.S. TO SELECTED AMP MEMBER TECHNOLOGISTS WHO DO NOT RECEIVE TRAVEL SUPPORT FROM THEIR INSTITUTIONS.</TypeOfAssistanceTxt>
        <RegionTxt>MIDDLE EAST AND NORTH AFRICA</RegionTxt>
        <RecipientCnt>1</RecipientCnt>
        <CashGrantAmt>1875</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK</MannerOfCashDisbursementTxt>
        <ValuationMethodUsedDesc>BOOK</ValuationMethodUsedDesc>
      </ForeignIndividualsGrantsGrp>
      <ForeignIndividualsGrantsGrp>
        <TypeOfAssistanceTxt>TECHNOLOGIST TRAVEL AWARD: TRAVEL ASSISTANCE TO THE AMP ANNUAL MEETING &amp; EXPO IN U.S. TO SELECTED AMP MEMBER TECHNOLOGISTS WHO DO NOT RECEIVE TRAVEL SUPPORT FROM THEIR INSTITUTIONS.</TypeOfAssistanceTxt>
        <RegionTxt>SOUTH ASIA</RegionTxt>
        <RecipientCnt>1</RecipientCnt>
        <CashGrantAmt>1500</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK</MannerOfCashDisbursementTxt>
        <ValuationMethodUsedDesc>BOOK</ValuationMethodUsedDesc>
      </ForeignIndividualsGrantsGrp>
      <TransferToForeignCorpInd>0</TransferToForeignCorpInd>
      <InterestInForeignTrustInd>0</InterestInForeignTrustInd>
      <ForeignCorpOwnershipInd>0</ForeignCorpOwnershipInd>
      <PassiveForeignInvestmestCoInd>0</PassiveForeignInvestmestCoInd>
      <ForeignPartnershipInd>0</ForeignPartnershipInd>
      <BoycottCountriesInd>0</BoycottCountriesInd>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART I, LINE 2:</FormAndLineReferenceDesc>
        <ExplanationTxt>ASSOCIATION FOR MOLECULAR PATHOLOGY HAS AN AWARDS COMMITTEE WHICH CHOOSES AWARD RECIPIENTS AND MONITORS THE USE OF THOSE AWARDS.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>SCHEDULE F, PART 1, LINE 3(E)</FormAndLineReferenceDesc>
        <ExplanationTxt>AMP EUROPE 2018 - THE INAUGURAL AMP EUROPE WAS HELD IN ROTTERDAM, THE NETHERLANDS, ON APRIL 30 - MAY 2, 2018, WITH 300 ATTENDEES, 30 EXHIBITORS, 18 EDUCATIONAL SESSIONS AND 60+ POSTERS. AWARDS WERE PRESENTED FOR TRAVEL, SUPPORT AND YOUNG INVESTIGATOR POSTER PRESENTATION.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleF>
    <IRS990ScheduleI documentId="RetDoc1041900001">
      <GrantRecordsMaintainedInd>1</GrantRecordsMaintainedInd>
      <GrantsOtherAsstToIndivInUSGrp>
        <GrantTypeTxt>YOUNG INVESTIGATOR AWARD 2018</GrantTypeTxt>
        <RecipientCnt>3</RecipientCnt>
        <CashGrantAmt>3000</CashGrantAmt>
      </GrantsOtherAsstToIndivInUSGrp>
      <GrantsOtherAsstToIndivInUSGrp>
        <GrantTypeTxt>AWARD FOR EXCELLENCE</GrantTypeTxt>
        <RecipientCnt>1</RecipientCnt>
        <CashGrantAmt>7500</CashGrantAmt>
      </GrantsOtherAsstToIndivInUSGrp>
      <GrantsOtherAsstToIndivInUSGrp>
        <GrantTypeTxt>TECHNOLOGIST TRAVEL AWARD</GrantTypeTxt>
        <RecipientCnt>1</RecipientCnt>
        <CashGrantAmt>1500</CashGrantAmt>
      </GrantsOtherAsstToIndivInUSGrp>
      <GrantsOtherAsstToIndivInUSGrp>
        <GrantTypeTxt>TECHNOLOGIST POSTER AWARD</GrantTypeTxt>
        <RecipientCnt>3</RecipientCnt>
        <CashGrantAmt>1500</CashGrantAmt>
      </GrantsOtherAsstToIndivInUSGrp>
      <GrantsOtherAsstToIndivInUSGrp>
        <GrantTypeTxt>JAK LEADERSHIP AWARD</GrantTypeTxt>
        <RecipientCnt>1</RecipientCnt>
        <CashGrantAmt>2500</CashGrantAmt>
      </GrantsOtherAsstToIndivInUSGrp>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART I, LINE 2:</FormAndLineReferenceDesc>
        <ExplanationTxt>ASSOCIATION FOR MOLECULAR PATHOLOGY HAS AN AWARDS COMMITTEE WHICH CHOOSES AWARD RECIPIENTS AND MONITORS THE USE OF THOSE AWARDS.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleI>
    <IRS990ScheduleJ documentId="RetDoc1042400001">
      <DiscretionarySpendingAcctInd>X</DiscretionarySpendingAcctInd>
      <WrittenPolicyRefTAndEExpnssInd>1</WrittenPolicyRefTAndEExpnssInd>
      <SubstantiationRequiredInd>1</SubstantiationRequiredInd>
      <CompensationCommitteeInd>X</CompensationCommitteeInd>
      <WrittenEmploymentContractInd>X</WrittenEmploymentContractInd>
      <CompensationSurveyInd>X</CompensationSurveyInd>
      <BoardOrCommitteeApprovalInd>X</BoardOrCommitteeApprovalInd>
      <SeverancePaymentInd>0</SeverancePaymentInd>
      <SupplementalNonqualRtrPlanInd>0</SupplementalNonqualRtrPlanInd>
      <EquityBasedCompArrngmInd>0</EquityBasedCompArrngmInd>
      <CompBasedOnRevenueOfFlngOrgInd>0</CompBasedOnRevenueOfFlngOrgInd>
      <CompBsdOnRevRelatedOrgsInd>0</CompBsdOnRevRelatedOrgsInd>
      <CompBsdNetEarnsFlngOrgInd>0</CompBsdNetEarnsFlngOrgInd>
      <CompBsdNetEarnsRltdOrgsInd>0</CompBsdNetEarnsRltdOrgsInd>
      <AnyNonFixedPaymentsInd>0</AnyNonFixedPaymentsInd>
      <InitialContractExceptionInd>0</InitialContractExceptionInd>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>MARY STEELE WILLIAMS MNA MT ASCPSM</PersonNm>
        <TitleTxt>EXECUTIVE DIRECTOR</TitleTxt>
        <BaseCompensationFilingOrgAmt>254012</BaseCompensationFilingOrgAmt>
        <CompensationBasedOnRltdOrgsAmt>0</CompensationBasedOnRltdOrgsAmt>
        <BonusFilingOrganizationAmount>0</BonusFilingOrganizationAmount>
        <BonusRelatedOrganizationsAmt>0</BonusRelatedOrganizationsAmt>
        <OtherCompensationFilingOrgAmt>0</OtherCompensationFilingOrgAmt>
        <OtherCompensationRltdOrgsAmt>0</OtherCompensationRltdOrgsAmt>
        <DeferredCompensationFlngOrgAmt>23982</DeferredCompensationFlngOrgAmt>
        <DeferredCompRltdOrgsAmt>0</DeferredCompRltdOrgsAmt>
        <NontaxableBenefitsFilingOrgAmt>21392</NontaxableBenefitsFilingOrgAmt>
        <NontaxableBenefitsRltdOrgsAmt>0</NontaxableBenefitsRltdOrgsAmt>
        <TotalCompensationFilingOrgAmt>299386</TotalCompensationFilingOrgAmt>
        <TotalCompensationRltdOrgsAmt>0</TotalCompensationRltdOrgsAmt>
        <CompReportPrior990FilingOrgAmt>0</CompReportPrior990FilingOrgAmt>
        <CompReportPrior990RltdOrgsAmt>0</CompReportPrior990RltdOrgsAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>TARA BURKE</PersonNm>
        <TitleTxt>SR. DIRECTOR, PUBLIC POLIC</TitleTxt>
        <BaseCompensationFilingOrgAmt>153437</BaseCompensationFilingOrgAmt>
        <CompensationBasedOnRltdOrgsAmt>0</CompensationBasedOnRltdOrgsAmt>
        <BonusFilingOrganizationAmount>0</BonusFilingOrganizationAmount>
        <BonusRelatedOrganizationsAmt>0</BonusRelatedOrganizationsAmt>
        <OtherCompensationFilingOrgAmt>0</OtherCompensationFilingOrgAmt>
        <OtherCompensationRltdOrgsAmt>0</OtherCompensationRltdOrgsAmt>
        <DeferredCompensationFlngOrgAmt>13388</DeferredCompensationFlngOrgAmt>
        <DeferredCompRltdOrgsAmt>0</DeferredCompRltdOrgsAmt>
        <NontaxableBenefitsFilingOrgAmt>8622</NontaxableBenefitsFilingOrgAmt>
        <NontaxableBenefitsRltdOrgsAmt>0</NontaxableBenefitsRltdOrgsAmt>
        <TotalCompensationFilingOrgAmt>175447</TotalCompensationFilingOrgAmt>
        <TotalCompensationRltdOrgsAmt>0</TotalCompensationRltdOrgsAmt>
        <CompReportPrior990FilingOrgAmt>0</CompReportPrior990FilingOrgAmt>
        <CompReportPrior990RltdOrgsAmt>0</CompReportPrior990RltdOrgsAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART I, LINE 1A - RELEVANT INFORMATION REGARDING COMPENSATION BENEFITS</FormAndLineReferenceDesc>
        <ExplanationTxt>THE AMP EXCUTIVE DIRECTOR SHALL HAVE USE OF A DISCRETIONARY EXPENSE ACCOUNT FOR OFFICE AND SPECIAL TRAVEL EXPENSES, PROFESSIONAL MEMBERSHIPS, SUBSCRIPTIONS, AND PRIVATE LONG-TERM CARE INSURANCE.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleJ>
    <IRS990ScheduleO documentId="RetDoc1044400001">
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION A, LINE 6</FormAndLineReferenceDesc>
        <ExplanationTxt>THE FOLLOWING ARE AMP'S MEMBERSHIP CATEGORIES: SEE WWW.AMP.ORG/MEMBERSHIP/JOIN-RENEWAL/ FOR ADDITIONAL DESCRIPTIONS. 1) REGULAR MEMBERS 2) TECHNOLOGIST MEMBERS 3) EARLY CAREER MEMBERS 4) ASSOCIATE MEMBERS (STUDENTS, FELLOWS, RESIDENTS) 5) EMERITUS MEMBERS (RETIRED REGULAR MEMBERS) 1) REGULAR MEMBERS ARE INDIVIDUALS INVOLVED IN THE EDUCATIONAL, MEDICAL, SCIENTIFIC, ECONOMIC, AND/OR REGULATORY ASPECTS OF MOLECULAR DIAGNOSTICS, INCLUDING BUT NOT LIMITED TO PATHOLOGISTS, CLINICAL LABORATORY SCIENTISTS, TECHNOLOGISTS, CLINICIANS AND OTHER HEALTH CARE PERSONNEL, GOVERNMENT EMPLOYEES, ESPECIALLY THOSE INVOLVED IN REGULATION OF THE FIELD, AND PROFESSIONALS IN THE IN VITRO DIAGNOSTICS INDUSTRY. REGULAR MEMBERS ARE ELIGIBLE TO VOTE, TO HOLD ELECTED OFFICE, AND TO SERVE ON AMP COMMITTEES. DUES RATES FOR REGULAR MEMBERS VARY DEPENDING ON THE INDIVIDUAL'S COUNTRY OF RESIDENCE AND PLACE OF EMPLOYMENT. VISIT THE MEMBERSHIP DUES RATES PAGE FOR DETAILS. 2) TECHNOLOGIST MEMBERS ARE INDIVIDUALS INVOLVED IN THE CLINICAL PRACTICE AND/OR RESEARCH ASPECTS OF MOLECULAR DIAGNOSTICS WHOSE PRIMARY DUTIES INVOLVE BENCH WORK, DEVELOPING AND/OR PERFORMING TESTS. TECHNOLOGIST MEMBERS ARE ELIGIBLE TO VOTE, TO HOLD ELECTED OFFICE, AND TO SERVE ON AMP COMMITTEES. DUES RATES FOR TECHNOLOGIST MEMBERS VARY DEPENDING ON THE INDIVIDUAL'S COUNTRY OF RESIDENCE AND PLACE OF EMPLOYMENT. VISIT THE MEMBERSHIP DUES RATES PAGE FOR DETAILS. 3) EARLY CAREER MEMBERS ARE INDIVIDUALS WHO WERE ASSOCIATE MEMBERS LAST YEAR AND ARE TRANSITIONING TO REGULAR MEMBER STATUS. DUES RATES FOR EARLY CAREER MEMEBERS VARY DEPENDING ON THE INDIVIDUAL'S COUNTRY OF RESIDENCE AND PLACE OF EMPLOYMENT. VISIT THE MEMBERSHIP DUES RATES PAGE FOR DETAILS. 4) ASSOCIATE MEMBERSHIP IS OPEN TO STUDENTS, POSTDOCTORAL FELLOWS, AND RESIDENTS AT A REDUCED RATE. ASSOCIATE MEMBERSHIP CARRIES ALL THE BENEFITS OF FULL MEMBERSHIP EXCEPT HOLDING ELECTED OFFICE AND VOTING RIGHTS IN AMP ELECTIONS. ASSOCIATE MEMBERS ARE ELIGIBLE TO BE CONSIDERED FOR A JUNIOR MEMBER POSITION ON THE COMMITTEES. CANDIDATES FOR ASSOCIATE MEMBERSHIP MUST INCLUDE COMMUNICATION FROM THEIR PROGRAM DIRECTOR CERTIFYING THE APPLICANT'S TRAINEE STATUS. ASSOCIATE MEMBERS HAVE THE OPTION TO PURCHASE A PRINT SUBSCRIPTION TO THE JOURNAL OF MOLECULAR DIAGNOSTICS TO SUPPLEMENT THE COMPLIMENTARY ONLINE SUBSCRIPTION. VISIT THE MEMBERSHIP DUES RATES PAGE FOR DETAILS. 5) EMERITUS MEMBERSHIP IS OPEN TO REGULAR MEMBERS WHO ARE RETIRED AND ARE NO LONGER RECEIVING EITHER FULL OR PART-TIME SALARY FROM AN INSTITUTION, COMPANY OR ORGANIZATION. CANDIDATES FOR THIS CATEGORY MUST HAVE BEEN A REGULAR AMP MEMBER FOR AT LEAST THE FIVE CONSECUTIVE YEARS IMMEDIATELY PRECEDING APPLICATION FOR EMERITUS STATUS. EMERITUS MEMBERSHIP CARRIES ALL THE BENEFITS OF FULL MEMBERSHIP EXCEPT THE ABILITY TO RUN FOR ELECTED OFFICE OR VOTE IN SOCIETY ELECTIONS. NOTE: AMP RESERVES THE RIGHT TO ACTIVATE OR INACTIVATE MEMBERSHIPS, IN ACCORDANCE WITH AMP BYLAWS AND OPERATING PROCEDURES.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION A, LINE 7A</FormAndLineReferenceDesc>
        <ExplanationTxt>THE MAJORITY OF THE BOARD OF DIRECTORS IS ELECTED BY AMP'S MEMBERSHIP. ONLY AMP'S REGULAR MEMBERS MAY RUN FOR OFFICE.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION B, LINE 11B</FormAndLineReferenceDesc>
        <ExplanationTxt>AMP'S FORM 990 IS INITIALLY REVIEWED, IN DRAFT FORM, BY THE EXECUTIVE DIRECTOR.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION B, LINE 12C</FormAndLineReferenceDesc>
        <ExplanationTxt>THE CONFLICTS OF INTEREST DISCLOSURE REPORTS ARE GIVEN TO THE EXECUTIVE DIRECTOR. THE EXECUTIVE DIRECTOR THEN MONITORS THE ISSUES AND ALERTS THE PRESIDENT AND RELEVANT COMMITTEE CHAIR OF ANY APPARENT CONFLICTS.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION B, LINE 15A</FormAndLineReferenceDesc>
        <ExplanationTxt>THE COMPENSATION OF THE EXECUTIVE DIRECTOR IS APPROVED BY THE BOARD OF DIRECTORS.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION C, LINE 19</FormAndLineReferenceDesc>
        <ExplanationTxt>AMP'S BYLAWS ARE AVAILABLE ON THE AMP WEBSITE.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART IX, LINE 11G</FormAndLineReferenceDesc>
        <ExplanationTxt>BOARD TRAINING: PROGRAM SERVICE EXPENSES 0. MANAGEMENT AND GENERAL EXPENSES 6,521. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 6,521. PROFESSIONAL DEVELOPMENT: PROGRAM SERVICE EXPENSES 0. MANAGEMENT AND GENERAL EXPENSES 14,892. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 14,892. FASEB: PROGRAM SERVICE EXPENSES 0. MANAGEMENT AND GENERAL EXPENSES 70,173. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 70,173. CONTRACTUAL: PROGRAM SERVICE EXPENSES 450,010. MANAGEMENT AND GENERAL EXPENSES 86,324. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 536,334.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleO>
  </ReturnData>
</Return>